Lenvima
Lenvima Plus Keytruda Approved for First-Line Treatment of Advanced RCC
The FDA approved the combination of lenvatinib (Lenvima, Eisai) plus pembrolizumab (Keytruda, Merck) for first-line ...
AUGUST 16, 2021
Keytruda Plus Lenvima Approved for Some Endometrial Cancer Pts
The FDA granted accelerated approval to the combination of pembrolizumab (Keytruda, Merck) plus lenvatinib ...
SEPTEMBER 18, 2019
FDA Approves HCC Indication for Lenvima
The FDA approved a new indication for Lenvima for first-line treatment of patients with unresectable hepatocellular ...
AUGUST 20, 2018
Load more